When pooled together, gliomas in which MGMT promoter methylation was determined by DNA methylation array using the Bady algorithm showed a VAF cutoff of 0.245 (Fig. 3A, Supplementary Figure S4A). Here, MGMT is linked to central nervous system cancer.